Celloid
PrivateLast Round
Series A
Mar 12, 2026
Est. Valuation
$26.32M
Total Funding Raised
$6.77M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Celloid operates in Healthcare & Life Sciences and is based in Pohang. Its latest recorded funding round was a Series A round in March 2026.
Celloid is a biotechnology company that develops and supplies three-dimensional (3D) cell culture automation systems and solutions for organoids and spheroids.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celloid Comparables
Compare Celloid with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CelVivo | 80% | |
| AIM Biotech | 79% | |
| mo:re | 78% |
For institutional investors. Book with your work email.
Celloid Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 12, 2026 | ||||
| VC Round | Jan 31, 2024 | ||||
| Seed | Jun 1, 2022 |
For institutional investors. Book with your work email.
Celloid Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| POSTECH Holdings Co., Ltd. | VC Round, Seed |
| FuturePlay | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2026
$7M round completed
- Jan 31, 2024
$1.8M round led by POSTECH Holdings and FuturePlay.
For institutional investors. Book with your work email.
Celloid Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Celloid's valuation, stock price, and market status.
Is Celloid a public or private company?
Celloid is a private company.
What is the current stock price of Celloid?
Celloid is a private company, so its shares have no public market price. Caplight tracks Celloid's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Celloid worth (valuation)?
Celloid's valuation is estimated at $26.3M based on funding round data.
Can I buy Celloid stock?
Celloid shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Celloid's last funding round?
Celloid's most recent funding round was Series A on March 12, 2026.
Who are the main investors in Celloid?
Key investors in Celloid include POSTECH Holdings Co., Ltd., FuturePlay.
Will Celloid IPO soon?
No public IPO plans have been announced for Celloid.
How can I track Celloid secondary market activity?
Caplight tracks bids, offers, and trades in Celloid's shares on secondary markets.